| Company/Division name | Syngene USA Inc |
| Parent company | Syngene International |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2025 |
| Capital investment ($): | 50 |
| Country(ies) from which reshored: | India |
| City reshored to: | Rockville |
| State(s) reshored to: | MD |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biologics manufacturing |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |
